Merck’s Capvaxive Seeks to Become the Primary Shot for Pneumococcal Disease Prevention
Capvaxive covers roughly 84% of serotypes responsible for pneumococcal disease in adults 50 years and older. Capvaxive is non-inferior to ...
Capvaxive covers roughly 84% of serotypes responsible for pneumococcal disease in adults 50 years and older. Capvaxive is non-inferior to ...
1. In a cohort of more than 1 million children treated for acute otitis media (AOM) in 2018, antibiotic treatment ...
1. Vaccination against the ten selected pathogens is projected to avert 69 million deaths between 2000 and 2030. 2. Increases ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.